Publication View

Rimonabant improves cardiometabolic risk factors in overweight/obese patients with poorly controlled type 2 diabetes (HbA(1c)>= 8%) on monotherapy with metformin or sulfonylureas (2006)

Scheen, André,
Finer, N,
Jensen, M,
Hollander, P,
Van Gaal, L

Publication details

Download	http://hdl.handle.net/2268/7169
Publisher	Springer, New York
Repository	ORBi - Open Repository and Bibliography (Belgium)
Type	Conference report
Language	English
Relation	Diabetologia, Diabetologia